These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 29588466)

  • 1. Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.
    Mancini SJ; Boyd D; Katwan OJ; Strembitska A; Almabrouk TA; Kennedy S; Palmer TM; Salt IP
    Sci Rep; 2018 Mar; 8(1):5276. PubMed ID: 29588466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells.
    Uthman L; Kuschma M; Römer G; Boomsma M; Kessler J; Hermanides J; Hollmann MW; Preckel B; Zuurbier CJ; Weber NC
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1083-1094. PubMed ID: 33048256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of TLR4 and PPARγ, Dependent on AMPK Signalling Pathway Contribute to Anti-Inflammatory Effects of Vaccariae Hypaphorine in Endothelial Cells.
    Sun H; Zhu X; Lin W; Zhou Y; Cai W; Qiu L
    Cell Physiol Biochem; 2017; 42(3):1227-1239. PubMed ID: 28683454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice.
    Day EA; Ford RJ; Lu JH; Lu R; Lundenberg L; Desjardins EM; Green AE; Lally JSV; Schertzer JD; Steinberg GR
    Biochem J; 2020 Jun; 477(12):2347-2361. PubMed ID: 32510137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway.
    Dabour MS; Abdelgawad IY; Grant MKO; El-Sawaf ES; Zordoky BN
    Biomed Pharmacother; 2023 Aug; 164():114907. PubMed ID: 37247463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway.
    Zhou J; Zhu J; Yu SJ; Ma HL; Chen J; Ding XF; Chen G; Liang Y; Zhang Q
    Biomed Pharmacother; 2020 Dec; 132():110821. PubMed ID: 33068934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.
    Hawley SA; Ford RJ; Smith BK; Gowans GJ; Mancini SJ; Pitt RD; Day EA; Salt IP; Steinberg GR; Hardie DG
    Diabetes; 2016 Sep; 65(9):2784-94. PubMed ID: 27381369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A769662 Inhibits Insulin-Stimulated Akt Activation in Human Macrovascular Endothelial Cells Independent of AMP-Activated Protein Kinase.
    Strembitska A; Mancini SJ; Gamwell JM; Palmer TM; Baillie GS; Salt IP
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canagliflozin Inhibits Glioblastoma Growth and Proliferation by Activating AMPK.
    Shoda K; Tsuji S; Nakamura S; Egashira Y; Enomoto Y; Nakayama N; Shimazawa M; Iwama T; Hara H
    Cell Mol Neurobiol; 2023 Mar; 43(2):879-892. PubMed ID: 35435536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
    Hwang HJ; Chung HS; Jung TW; Ryu JY; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
    Mol Cell Endocrinol; 2015 Apr; 405():25-34. PubMed ID: 25661535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGLT2-independent effects of canagliflozin on NHE3 and mitochondrial complex I activity inhibit proximal tubule fluid transport and albumin uptake.
    Albalawy WN; Youm EB; Shipman KE; Trull KJ; Baty CJ; Long KR; Rbaibi Y; Wang XP; Fagunloye OG; White KA; Jurczak MJ; Kashlan OB; Weisz OA
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1041-F1053. PubMed ID: 38660713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
    Hattori Y; Suzuki K; Hattori S; Kasai K
    Hypertension; 2006 Jun; 47(6):1183-8. PubMed ID: 16636195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement.
    Alsereidi FR; Khashim Z; Marzook H; Gupta A; Al-Rawi AM; Ramadan MM; Saleh MA
    Curr Probl Cardiol; 2024 May; 49(5):102524. PubMed ID: 38492622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.
    Kaji K; Nishimura N; Seki K; Sato S; Saikawa S; Nakanishi K; Furukawa M; Kawaratani H; Kitade M; Moriya K; Namisaki T; Yoshiji H
    Int J Cancer; 2018 Apr; 142(8):1712-1722. PubMed ID: 29205334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive effects of SGLT2 inhibitors on angiogenesis in zebrafish embryos.
    Huttunen R; Sainio A; Hjelt A; Haapanen-Saaristo AM; Määttä J; Rummukainen P; Paatero I; Järveläinen H
    Biomed Pharmacother; 2022 Dec; 156():113882. PubMed ID: 36265308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells.
    Xu C; Wang W; Zhong J; Lei F; Xu N; Zhang Y; Xie W
    Biochem Pharmacol; 2018 Jun; 152():45-59. PubMed ID: 29551587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Inhibits the Production of IL-1β-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-κB Signaling Pathways.
    Cheng SC; Huang WC; S Pang JH; Wu YH; Cheng CY
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of S-adenosylhomocysteine hydrolase in inhibition of TNF-alpha- and IL-1beta-induced expression of inflammatory mediators by AICAR in RPE cells.
    Qin S; Ni M; De Vries GW
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1274-81. PubMed ID: 18326758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-
    Lee N; Heo YJ; Choi SE; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
    J Immunol Res; 2021; 2021():9944880. PubMed ID: 34124273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.